[144] Symbotic Inc. SEC Filing
Form 144 filed for Symbotic Inc. (SYM) reports a proposed sale of 25,000 common shares via Morgan Stanley Smith Barney (Exec Financial Services) with an aggregate market value of $1,414,250 and an approximate sale date of 08/05/2025 on NASDAQ.
The filing shows the 25,000 shares were acquired as Restricted Stock Units on 01/23/2025, with 109,080,019 shares outstanding reported. The form lists multiple prior 10b5-1 sales by William Boyd III in 2025 (07/10, 07/15, 06/16, 08/01) totaling 41,850 shares for gross proceeds of $2,022,972.80. Several issuer and filer identification fields in the filing appear blank in the provided content. The filing includes the standard representation regarding material nonpublic information and signature attestation.
- Planned sale disclosed with broker details (Morgan Stanley Smith Barney) and an explicit approximate sale date (08/05/2025).
- Securities acquisition method and date disclosed: 25,000 shares were issued as Restricted Stock Units on 01/23/2025.
- Prior 10b5-1 sales reported, providing transparency for recent insider liquidity activity.
- Multiple insider sales in prior three months: 41,850 shares sold across four 10b5-1 transactions (06/16/2025�08/01/2025).
- Gross proceeds reported for recent sales total $2,022,972.80, indicating notable insider liquidity during 2025.
- Key issuer/filer identification fields appear blank in the provided extract, reducing contextual clarity in this copy of the filing.
Insights
TL;DR: Routine insider sales via 10b5-1 and RSU liquidation; not obviously material to valuation given share count disclosed.
The filing documents a planned sale of 25,000 common shares (aggregate value $1.41M) executed through Morgan Stanley with an approximate trade date of 08/05/2025. The shares were RSUs acquired 01/23/2025. Recent 10b5-1 transactions show 41,850 shares sold in the prior three months for gross proceeds of $2.02M. For investors, these are transparent disclosures of insider liquidity rather than an operational signal; issuer and some filer identification fields are blank in the provided extract, limiting further context.
TL;DR: Disclosure aligns with Rule 144 and 10b5-1 practices; documentation is procedural and neutral absent additional context.
The form identifies the broker and sale mechanics and confirms the seller's representation about material nonpublic information. The record of multiple 10b5-1 sales in 2025 is consistent with pre-arranged trading plans. Missing issuer/filer detail in the provided content reduces traceability; governance reviewers will note the completeness of signature and plan adoption dates if present elsewhere. Overall, the filing is a standard insider sale disclosure.